Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 10
Submit an article Journal homepage
227
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

The prognostic significance of bone marrow involvement in diffuse large B cell lymphoma according to the flow cytometry

Uri GreenbaumDepartment of Hematology, Soroka University Medical Center, Beer Sheba, Israel; ;Faculty of Health Sciences, Ben-Gurion University, Beer Sheba, Israel; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-8582-4572View further author information
ORCID Icon,
Itai LeviDepartment of Hematology, Soroka University Medical Center, Beer Sheba, Israel; ;Faculty of Health Sciences, Ben-Gurion University, Beer Sheba, Israel; View further author information
,
Odelia MadmoniDepartment of Hematology, Soroka University Medical Center, Beer Sheba, Israel; ;Faculty of Health Sciences, Ben-Gurion University, Beer Sheba, Israel; View further author information
,
Yotam LiorFaculty of Health Sciences, Ben-Gurion University, Beer Sheba, Israel; ;Soroka Clinical Research Center, Soroka University Medical Center, Beer Sheba, Israel; ORCID Iconhttp://orcid.org/0000-0002-4255-9385View further author information
ORCID Icon,
Kayed Al-AthamenDepartment of Hematology, Soroka University Medical Center, Beer Sheba, Israel; ;Faculty of Health Sciences, Ben-Gurion University, Beer Sheba, Israel; View further author information
,
Zvi Howard PerryFaculty of Health Sciences, Ben-Gurion University, Beer Sheba, Israel; ;Surgery Ward A, Soroka University Medical Center, Beer Sheba, IsraelView further author information
,
Lev HatzkelzonDepartment of Hematology, Soroka University Medical Center, Beer Sheba, Israel; ;Faculty of Health Sciences, Ben-Gurion University, Beer Sheba, Israel; View further author information
&
George ShubinskyDepartment of Hematology, Soroka University Medical Center, Beer Sheba, Israel; ;Faculty of Health Sciences, Ben-Gurion University, Beer Sheba, Israel; View further author information
 show all
Pages 2477-2482 | Received 05 Nov 2018, Accepted 19 Feb 2019, Published online: 24 Apr 2019

References

  • Teras LR, DeSantis CE, Cerhan JR, et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66:443–459.
  • Smith A, Crouch S, Lax S, et al. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network. Br J Cancer. 2015;112:1575.
  • Chaganti S, Illidge T, Barrington S, et al. Guidelines for the management of diffuse large B-cell lymphoma. Br J Haematol. 2016;174:43–56.
  • Owens C, Younes A. Staging. Handbook of Lymphoma. Switzerland: Springer; 2016. p. 27–31.
  • Yan Y, Chan W, Weisenburger D, et al. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J Clin Oncol. 1995;13:1336–1342.
  • Campbell J, Seymour JF, Matthews J, et al. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. Eur J Haematol. 2006;76:473–480.
  • Sehn LH, Scott DW, Chhanabhai M, et al. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2011;29:1452–1457.
  • Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–3067.
  • Tilly H, Gomes da Silva M, Vitolo U, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:v116–vv25.
  • Kurtz DM, Green MR, Bratman SV, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 2015;125:3679–3687.
  • Stacchini A, Demurtas A, Godio L, et al. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10–18.
  • Al-Mawali A, Gillis D, Lewis I. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia. Am J Clin Pathol. 2009;131:16–26.
  • Sah S, Matutes E, Wotherspoon A, et al. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. J Clin Pathol. 2003;56:129–132.
  • Norris D, Stone J. WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva: WHO. 2008, 22–23.
  • Talaulikar D, Shadbolt B, Bell J, et al. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective. Histopathology. 2008;52:340–347.
  • Talaulikar D, Shadbolt B, Dahlstrom JE, et al. Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI). J Hematol Oncol. 2009;2:49.
  • Kim B, Lee S-T, Kim H-J, et al. Bone marrow flow cytometry in staging of patients with B-cell non-Hodgkin lymphoma. Ann Lab Med. 2015;35:187–193.
  • Wolach O, Fraser A, Luchiansky M, et al. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study. Hematol Oncol. 2015;33:42–47.
  • Pelosi E, Penna D, Douroukas A, et al. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. Quart J Nuclear Med Mol Imag. 2011;55:469–475.
  • Berthet L, Cochet A, Kanoun S, et al. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. J Nuclear Med. 2013;54:1244–1250.
  • Khan AB, Barrington SF, Mikhaeel NG, et al. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Blood. 2013;122:61–67.
  • Thiyagarajah K, Kamel-Hasan O, Hawsawy A, et al. The efficacy of PET-CT in detecting bone marrow involvement in patients with newly diagnosed lymphoma: a retrospective study. Blood. 2017;130:4160.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.